Gilead Sciences, Inc. completed the acquisition of 77.2% stake in Arcellx, Inc. from New Enterprise Associates, Inc., Sr One Capital Fund I Aggregator, LP, fund managed by SR One Capital Management, LP, and others.

Published: 2026-04-28 11:45:52 ET ACLX

Published on 04/28/2026 at 11:45 am EDT